Novartis’ breast cancer drug LEEO11 gains breakthrough statusDrug will challenge Pfizer’s Ibrance Share XNovartis’ breast cancer drug LEEO11 gains breakthrough statushttps://pharmaphorum.com/news/novartis-breast-cancer-drug-leeo11-gains-breakthrough-status/